Dr. Gordon Vanscoy,
PharmD, MBA, CACP

Chairman & CEO

With more than three decades of executive experience creating and developing successful medical and pharmaceutical service business ventures, Dr. Vanscoy is a recognized leader in the health care industry and a pioneer in the specialty pharmacy (SP) sector. He is the founding Chairman and CEO of RareMed® Solutions. Gordon also leads PANTHERx Specialty Pharmacy and serves as Associate Dean for Business Innovation and Associate Professor of Pharmacy and Therapeutics at the University of Pittsburgh (Pitt), where he recently launched the Master of Science in Pharmacy Business Administration degree program.

Prior to starting RareMed Solutions, Dr. Vanscoy founded PANTHERx Specialty Pharmacy, The Rare Disease SP®, served as the Chairman and CEO of WellCo Medical Solutions Inc., GreenCare US, LLC, and University Pharmacotherapy Associates Inc. Earlier in his career, while serving as Assistant Dean for Managed Care at Pitt, Gordon helped to grow one of the country’s first specialty pharmacy’s, Stadtlanders. He rose as an executive with Bergen Brunswig Specialty, and became Executive Vice President and Chief Operating Officer at CVS ProCare. Prior to specialty pharmacy, Gordon served as Vice-Chair of the Department of Pharmacy and Therapeutics where he founded UPMC’s Drug Information and Pharmacoepidemiology Center. He was an active member of the University Biomedical Institutional Review Board, serving as Vice Chairman. At the beginning of his career, he developed one of the country’s first Anticoagulation Clinic Services and obtained medication-prescribing privileges at the Pittsburgh Veterans Affairs Health System.

Dr. Vanscoy received his Bachelors of Science in Pharmacy and Masters of Business Administration degrees from the University of Pittsburgh, and his Doctor of Pharmacy degree from Duquesne University. Gordon completed an American Society of Health System Pharmacists (ASHP)-accredited clinical residency at The Mercy Hospital of Pittsburgh and a faculty fellowship in advanced geriatrics at the University of Pittsburgh Geriatric Education Center. He is nationally credentialed as a Certified Anticoagulation Care Provider.

In 2017, Dr. Vanscoy was awarded the University of Pittsburgh’s highest recognition, the Distinguished Alumni Fellow Award. In 2017, the Pittsburgh Business Times acknowledged him with a Pittsburgh Outstanding CEO and Top Executive Award. Gordon was recognized in 2016 by Smart Business Magazine as the top executive of one of the 50 smartest companies in the Western Pennsylvania for his ability to effectively build and lead successful organizations. He has published a number of textbook chapters, hundreds of scientific papers, and has received dozens of research grants and awards. Dr. Vanscoy has provided nearly a thousand invited lectures and served on many national and international committees. He is a past board member of the International Society of Pharmaceutical Outcomes (ISPOR), the ACPE National CE Provider Committee, the United States Pharmacopoeia’s (USP) Therapeutic Information Management Advisory Panel, the National Certified Anticoagulation Care Providers (CACP), the ASHP Foundation, and the American Red Cross. Gordon currently serves on the Board of Directors of the National Association of Specialty Pharmacy.

Dr. Douglas Gebhard,
PharmD, MBA

President

Dr. Douglas Gebhard brings to RareMed a unique background in the pharmaceutical services industry. He has held leadership positions with increasing responsibility at a number of large and growing pharmacy organizations which includes extensive experience in product development, operations, quality management, compliance, and clinical education. In his current role of President, RareMed Solutions, Dr. Gebhard works closely with his Executive team to ensure collaboration across all areas of the organization.

Prior to joining RareMed, Dr. Gebhard served as the VP of Pharmacy Services for PANTHERx® Rare Pharmacy.  He was responsible for overall operations and management at PANTHERx, including distribution, reimbursement, quality, compliance, and clinical education.  In addition, he also served as the program director for the PANTHERx Rare Fellowship which he helped to develop and implement.  Prior to leading all of Pharmacy Services for PANTHERx Rare, Dr. Gebhard served as Vice President of Quality & Education where he was responsible for compliance, accreditation, and strategic quality improvement.  In this role Gebhard also chaired the Quality Management Committee and the Clinical Oversight Committee. His efforts helped the company earn the highest score ever attained in the Zitter Health Insights Patient Satisfaction Survey including back-to-back Patient Choice awards in 2017 and 2018.

Earlier in his career, Doug led a cross-functional multidisciplinary team at CVS Health within Enterprise Product Innovation and Development. His team was responsible for the research, development, and implementation of patient-oriented healthcare initiatives and services.  His portfolio had a specific focus on developing products, services, and initiatives to redefine the role that CVS/pharmacy played in improving health outcomes for its patients and partners by directly addressing medication non-adherence.

Dr. Gebhard graduated from the University of Pittsburgh School of pharmacy with his Doctor of Pharmacy degree.  Additionally, Doug received his Masters of Business Administration from the Joseph M. Katz Graduate School of Business at the University of Pittsburgh.

Vickie Hunt,
MS HRM, BSN, RN, MSCN

Senior Vice President, Client Services

Vickie Hunt, Senior Vice President (SVP) at RareMed Solutions, has been with the organization since its inception, and is responsible for overseeing Client Services and HUB Program Operations of RareSupport teams.

Prior to joining RareMed, Vickie leveraged her extensive years of solid clinical expertise in a variety of leadership positions across multiple business units and disease states including neurology, oncology, immunology, endocrinology, renal and liver transplantation. Vickie worked alongside Bayer Healthcare managing field and call center nurses for a comprehensive education, training, and patient assistance support program for injectable therapy. Vickie has partnered with Janssen Biotech and Novartis Pharmaceuticals, to lead customized remote teams for their General Medicine, Oncology and Rare Disease Franchises. Committed to excellence in healthcare delivery, Vickie recruited and launched a variety of successful national teams to provide clinical solutions, field reimbursement, navigator support, and access delivery for multiple complex specialty pharmacy products.

Vickie Hunt began her professional nursing career at the University of Pittsburgh Medical Center (UPMC Presbyterian). During this time, Vickie held several diverse clinical and management positions which encompassed surgical, trauma, ICU, ER, Case Management and Director leadership roles. Vickie had the privilege of working closely with Dr. Thomas Starzl, pioneer of liver transplantation.

Vickie Hunt earned her Master’s degree in Human Resource Management in Administration from LaRoche College, received a Bachelor of Science in Nursing from Duquesne University, as well as an undergraduate Bachelor of Science degree in Biology from Juniata College. Vickie holds an Account Management Certification from Kennesaw State University and additionally, is certified in Multiple Sclerosis. Vickie Hunt is a member of several professional organizations, including the National Multiple Sclerosis Society (NMSS), International Organization of Multiple Sclerosis Nurses (IOMSN), and the Oncology Nursing Society (ONS).

Gannon Vanscoy,
MPBA

Vice President, Strategy

As the Vice President of Strategy at RareMed , Gannon oversees strategic initiatives, including market research, new product/service development, product enhancements, strategic planning, vendor management, contract renewal, and pricing.

Gannon has been with RareMed since its formation in 2017 and has served in various leadership positions throughout the organization, most recently serving as Vice President of Markets and Analytics. Gannon has extensive experience in rare disease and specialty pharmacy, previously serving as the Director of Rare Markets and various other leadership positions at PANTHERx Rare Pharmacy. Gannon was a member of the deal team representing PANTHERx in the 2020 sale to Centene Corporation, leveraging his prior corporate investment banking experience.

Earlier in his career, Gannon served as a leader at a number large multinational banks, both in internal and client-facing roles covering healthcare and insurance sectors. Gannon’s experience as a relationship director resulted in facilitating numerous acquisition financings for institutional clients.

Gannon received his Bachelor of Business Administration from the University of Miami and Masters of Pharmacy Business Administration from the University of Pittsburgh. He has published original articles in peer-reviewed publications. In 2019 Gannon was recognized by Pittsburgh Business Times as a 30 Under 30 honoree.

Gordon Vanscoy, Jr.,
MBA

Vice President, Business Operations

Gordon supports RareMed’s patient-facing team by leading many of the company’s behind-the-scenes teams, including Finance, Human Resources, and Marketing.  By managing these business operations, Gordon ensures that the rest of the team can focus on delivering the highest quality care to patients.

Before joining RareMed, Gordon served in a variety of roles as a finance and communications leader at one of the world’s largest airlines.  Gordon brings to RareMed a wide range of experience, including billion-dollar capital transaction management, controller team management, data analytics, business partner relations, and corporate communications.  Gordon began cultivating his expertise in rare and orphan disease states at PANTHERx Rare Pharmacy, where he provided communications and marketing support.

Gordon received his Bachelors of Science in Business Administration from Carnegie Mellon University’s Tepper School of Business and his Masters of Business Administration from Duke University’s Fuqua School of Business, where he concentrated in Health Sector Management.

William Valenta,
MBA

Vice President, Technology & Analytics

Bill brings over 30 years of managerial and executive experience across multiple industries and organizations to RareMed.​

​

Prior to joining RareMed, Bill was a member of the leadership team at PANTHERx Rare overseeing business operations wherein he built teams in technology, quality, training and human resources that directly impacted the growth and success of PANTHERx. Prior to his time at PANTHERx, Bill served as the Associate Vice Provost for Professional Programs at the University of Pittsburgh, where he focused on supporting the strategic development of Pitt’s professional degree programs across the campus. He previously served as Assistant Dean for MBA & Executive Programs at the University of Pittsburgh’s Katz Graduate School of Business. Before taking his first position as part of the Katz Graduate School of Business, Bill was the Assistant Chair of the University of Pittsburgh’s Department of Chemistry from 2005-2007. While at Pitt, Bill taught courses in leadership, ethics, strategic planning and crisis management at the undergraduate, graduate and executive education programs.​

​

Prior to his career in academia, Bill was a 22-year member of the Pittsburgh Bureau of Police, where he held multiple positions, eventually retiring with the rank of Commander. Bill holds a Bachelor of Science from Point Park University and a Master of Business Administration from the University of Pittsburgh.​

Dr. Justin Smerker,
PharmD, MPBA

Vice President, Business Development & Strategy

Dr. Smerker brings over twenty years of pharmacy and patient services experience to RareMed with the past decade focused on rare disease program development and launch, patient services, and specialty pharmacy offerings.  As a registered pharmacist and member of the RareMed leadership team, Dr. Smerker supports business development, implementation services, and strategic initiatives for rare and complex conditions.  Smerker, sets short and long-term business development strategies against company-wide targets, actively identifies a new business pipeline, and contributes to the capabilities narrative raising the profile of RareMed.

Prior to joining RareMed, Dr. Smerker spent eight years at PANTHERx Rare where he held multiple roles encompassing business development, account management, implementation, and clinical services functions.  During his tenure with PANTHERx, the company achieved exceptional organic growth both in revenue and specialty pharmacy market share.  He has served in a variety of leadership positions with increasing responsibility for both specialty and community pharmacy organizations.  Dr. Smerker has also served as a subject matter expert for the development of rare disease distinction standards by nationally recognized specialty pharmacy accreditation bodies.  Additionally, he has authored numerous industry articles and has been a featured speaker on specialty pharmacy topics.  He has held senior leadership roles working for both privately held and Fortune 25 publicly traded companies.

Smerker has wide-ranging experience in business development, patient services, specialty pharmacy contracting, and exclusive/semi-exclusive product launch strategy across multiple rare disease therapeutic areas including oncology, hematology, metabolics, nephrology, hepatology, and infectious disease.

He earned his PharmD. degree and Master of Pharmacy Business Administration (MPBA) degree, an executive-style program designed for leaders in the business of medicines, from the University of Pittsburgh School of Pharmacy and Joseph M. Katz Graduate School of Business.

Dr. Rami Chammas,
PharmD, MPBA

Senior Director, Pharmacy Services

Dr. Rami Chammas is an implementation and project management expert that has a proven track record leading initiatives at RareMed that infuse positive organizational change. He developed RareMed’s comprehensive and consistent framework to onboard manufacturing partners and successfully launch their branded support programs.

Rami oversees the innovation and implementation team by generating and executing positive change to enhance program and technology offerings. He has experience designing, building, testing and transitioning a variety of patient, prescriber and program support services. Rami also oversees systems implementation, managing the roadmap for RarePathTM – RareMed’s proprietary technology.

Dr. Chammas and his team serve as dedicated points of contact to manufacturing partners from project inception to hyper-support post-launch. His launch experience results in the implementation of comprehensive solutions across many disease states, and his transition experience allows RareMed to streamline and enhance programs transitioned from alternate patient service providers.

In a previous role, Dr. Chammas served as the Director of Pharmacy Services, overseeing pharmacy operations and non-commercial pharmacy program services. Rami worked with his team to deliver support to patients afflicted with rare conditions and to ensure that they received the medications they need.

Prior to joining RareMed, Rami began his journey through Specialty Pharmacy at PANTHERx Rare Pharmacy, where he was involved in projects across many departments including quality, product development, and strategic partnerships.

Dr. Chammas received his Doctor of Pharmacy degree from the University of Pittsburgh School of Pharmacy and his Master of Pharmacy Business Administration from the University of Pittsburgh Katz School of Business, with a Specialty Pharmacy Management focus track.

Diane Hamilton

Director, Implementation and Solution Development

Christine Reuschel

Director, Analytics

Phillip Krall

Director, Software Development

Phill’s bio will be loaded shortly!

Jennifer Sprague,
MHA

Account Director

Jennifer Sprague is an Account Director overseeing the management of operations for several of RareMed’s oncology programs. Jennifer is the primary point of contact for clients to advise on internal and external inquiries. Jennifer has extensive leadership experience in clinical research and molecular genetics, with expertise in patient advocacy, sales and account management, client services, and revenue cycle.

Prior to joining RareMed in 2023, Jennifer was the Director of Patient and Client Account Management with Interpace Diagnostics, overseeing client services, revenue cycle, patient support and supporting clinical development. Jennifer spent many years in clinical research and the management of clinical trials, with experience in cellular therapy, transplantation, medical devices, and pharmaceuticals.

Jennifer received her Bachelor of Science in Microbiology from the Ohio State University and Master of Health Administration from Ohio University.

Nate Boal,
MBA

Account Director

Nate Boal is an Account Director that is dedicated to the management of operations for one of RareMed’s programs. Nate serves as a trusted client advisor and is the primary point of contact for all internal and external inquiries. Nate has extensive leadership experience in pharmaceutical reimbursement, case management, market access, data analysis, and LTC services.

Nate has been with RareMed since 2019 and has been instrumental in implementing multiple program launches and transitions. Nate has worked on a variety of diverse programs with a primary focus on neurocognitive indications.

Before joining RareMed, Nate worked in a variety of leadership roles at ZOLL Lifecor, with a primary focus on reimbursement market access and clinical trials for a wearable defibrillator.

Nate received his Bachelor of Science degree in Marketing and Master of Business Administration degree from California University of Pennsylvania.

Heather Len

Account Director

Mary Beth Toth,
PHR, SHRM-CP

Manager, Human Resources

As the Manager of Human Resources at RareMed Solutions, Mary Beth Toth is responsible for recruitment, performance management, employee relations, training, and employee benefits.

Mary Beth has over 15 years of progressive human resources experience in several industries including technology, health care, and education. Prior to joining RareMed Solutions, Mary Beth was the human resources manager responsible for all HR programs at Fi360. She credits the deep connections she made with the employees for making her time with Fi360 some of her professional best. One of her favorite positions was an internship for her favorite sports team, the Chicago White Sox. Mary Beth is a proud Chicago native, but she has felt right at home in her adopted city of Pittsburgh since 2014.

Mary Beth holds a bachelors degree from Loyola University Chicago. She received her Professional in Human Resources (P.H.R.) designation in 2010 and her Society of Human Resources Management – Certified Professional (SHRM-CP) designation in 2015.